Advances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series copmrising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in Medicinal Chemistry. The first volume presents reviews of many classes of drugs of contemporary interest for cancer therapy and is devoted to small inhibitors of various proteins involved in cancer development such as casein kinase 2 (CK2), protein kinase B (PKB), mTOR, Hsp90, P-glycoprotein (P-gp), kinesin spindle protein (KSP), cyclooxygenase 2 (COX-2), histone deacetylase enzymes (HDACs) and topoisomerase I.Advances in Anticancer Agents in Medicinal Chemistry will be of particular interest to readers interested in anticancer drug therapy as the series provides relevant reviews written by experts in this important field.